Data as of 3:59pm ET
| +0.10 / +7.52%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.50. The median estimate represents a +109.79% increase from the last price of 1.43.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.